Showing results (471-480 of 4,498) with videos related to
Sort By:
Pageof 450
Journal of Internal Medicine|March 11, 2014
Biomarkers: refining diagnosis and expediting drug development - reality, aspiration and the role of open innovationH Salter, R HollandJournal of Internal Medicine|April 11, 2017
Intestinal alkaline phosphatase at the crossroad of intestinal health and disease - a putative role in type 1 diabetesM I Lassenius, C L Fogarty, M Blaut, et al.Journal of Internal Medicine|June 10, 2008
Determinants of plasma apolipoprotein A-V and APOA5 gene transcripts in humansP Hahne, F Krempler, F G Schaap, et al.Journal of Internal Medicine|June 12, 2008
Revisiting human primary immunodeficienciesJean-Laurent Casanova, Claire Fieschi, Shen-Ying Zhang, et al.Journal of Internal Medicine|September 1, 2019
We know DAAs work, so now what? Simplifying models of care to enhance the hepatitis C cascadeJ V Lazarus, J M Pericàs, C Picchio, et al.Journal of Internal Medicine|September 6, 2019
Coffee intake protects against symptomatic gallstone disease in the general population: a Mendelian randomization studyA T Nordestgaard, S Stender, B G Nordestgaard, et al.Journal of Internal Medicine|August 9, 2019
D-dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registryO Avnery, M Martin, A Bura-Riviere, et al.Journal of Internal Medicine|January 4, 1998
Proinflammatory cytokines, measured in a mixed population on arrival in the emergency department, are related to mortality and severity of diseaseF Carlstedt, L Lind, B LindahlJournal of Internal Medicine|January 4, 1998
The effects of thromboxane A2 inhibition (picotamide) and angiotensin II receptor blockade (losartan) in primary Raynaud's phenomenonP Pancera, S Sansone, S Secchi, et al.Journal of Internal Medicine|January 4, 1998
The anti-oestrogen tamoxifen produces haemodilution in normal postmenopausal womenA B Grey, M C Evans, C Kyle, et al.Pageof 450